Discriminative stimulus effects of flumazenil: Perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone

Behavioural Pharmacology

Volumn 17, Issue 3, 2006, Pages 239-247

  Koek, Wouter ^a   Carter, Lawrence P ^a   Wu, Huifang ^b   Coop, Andrew ^b   France, Charles P ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

hydroxybutyrate; Drug discrimination; Flumazenil; Pigeon

Indexed keywords

1,4 BUTANEDIOL; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 3 AMINOPROPYL(METHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 4 HYDROXYBUTYRIC ACID; 6,7,8,9 TETRAHYDRO 5 HYDROXY 5H BENZOCYCLOHEPT 6 YLIDENEACETIC ACID; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; ACETIC ACID DERIVATIVE; BACLOFEN; DIAZEPAM; FLUMAZENIL; GABOXADOL; GAMMA BUTYROLACTONE; KETAMINE; MORPHINE; MUSCIMOL; NCS 382; PENTOBARBITAL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DISCRIMINATION; DRUG EFFECT; DRUG RESPONSE; DRUG SELECTIVITY; DRUG SUBSTITUTION; EXPERIMENTAL MODEL; IN VIVO STUDY; MASKING; NONHUMAN; PERCEPTION; PIGEON; PRECURSOR; SHIFT TO THE RIGHT; TRAINING;

4-BUTYROLACTONE; ANIMALS; BACLOFEN; BENZOCYCLOHEPTENES; BUTYLENE GLYCOLS; COLUMBIDAE; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FLUMAZENIL; GABA AGONISTS; GABA ANTAGONISTS; GABA MODULATORS; ORGANOPHOSPHORUS COMPOUNDS; RECEPTORS, GABA-A; RECEPTORS, GABA-B; SODIUM OXYBATE;

EID: 33645702650     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200605000-00005     Document Type: Article

References (33)

1. Acri JB, Wong G, Witkin JM (1995). Stereospecific transduction of behavioral effects via diazepam-insensitive GABAA receptors. Eur J Pharmacol 278:213-223.
2. Acri JB, Wong G, Lyon T, Witkin JM, Basile AS (1997). Localization and pharmacological characterization of pigeon diazepam-insensitive GABAA receptors. Neuroscience 77:371-378.
3. Ator NA, Griffiths RR (1989). Asymmetrical cross-generalization with lorazepam and pentobarbital training conditions. Drug Dev Res 16:355-364.
4. Barry HI, Krimmer EC (1978). Similarities and differences in discriminative stimulus effects of chlordiazepoxide, pentobarbital, ethanol and other sedatives. In: Colpaert FC, Rosecrans JA, editors. Stimulus properties of drugs: ten years of progress. Amsterdam: Elsevier-North Holland. pp. 31-51.
5. Brandt MR, France CP (1996). Discriminative stimulus effects on enadoline in pigeons. J Pharmacol Exp Ther 277:960-967.
6. Carai MA, Colombo G, Brunetti G, Melis S, Serra S, Vacca G, et al. (2001). Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol 428:315-321.
7. Carter LP, Flores LR, Wu H, Chen W, Unzeitig AW, Coop A, France CP (2003). The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies. J Pharmacol Exp Ther 305:668-674.
8. Colpaert FC (1977). Discriminative stimulus properties of benzodiazepines and barbiturates. In: Lal H, editor. Discriminative stimulus properties of drugs. New York: Plenum. pp. 93-106.
9. Cook CD, Aceto MD, Coop A, Beardsley PM (2002). Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gamma-hydroxybutyrate in mice. Psychopharmacology (Berlin) 160:99-106.
10. Dantzer R, Perio A (1982). Behavioural evidence for partial agonist properties of Ro 15-1788, a benzodiazepine receptor antagonist. Eur J Pharmacol 81:655-658.
11. De Vry J, Slangen JL (1985a). Stimulus control induced by benzodiazepine antagonist Ro 15-1788 in the rat. Psychopharmacology 85:483-485.
12. De Vry J, Slangen JL (1985b). The Ro 15-1788 cue: evidence for benzodiazepine agonist and inverse agonist properties. Eur J Pharmacol 119:193-197.
13. De Vry J, Slangen JL (1986a). Effects of chlordiazepoxide training dose on the mixed agonist-antagonist properties of benzodiazepine receptor antagonist Ro 15-1788, in a drug discrimination procedure. Psychopharmacology 88:177-183.
14. De Vry J, Slangen JL (1986b). Effects of training dose on discrimination and cross- generalization of chlordiazepoxide, pentobarbital and ethanol in the rat. Psychopharmacology 88:341-345.
15. Edgington ES (1995). Randomization tests. New York: Marcel Dekker.
16. Gauvin DV, Young AM (1989). Evidence for perceptual masking of the discriminative morphine stimulus. Psychopharmacology (Berlin) 98:212-221.
17. Gauvin DV, Peirce JM, Holloway FA (1994). Perceptual masking of the chlordiazepoxide discriminative cue by both caffeine and buspirone. Pharmacol Biochem Behav 47:153-159.
18. Grant KA (1999). Strategies for understanding the pharmacological effects of ethanol with drug discrimination procedures. Pharmacol Biochem Behav 64:261-267.
19. Hunkeler W, Mohler H, Pieri L, Polc P, Bonetti EP, Cumin R, et al. (1981). Selective antagonists of benzodiazepines. Nature 290:514-516.
20. Koek W, Flores LR, Carter LP, Lamb RJ, Chen W, Wu H, et al. (2004). Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) in pigeons: role of diazepam-sensitive and -insensitive GABAA receptors, and of GABAB receptors. J Pharmacol Exp Ther 309:540-547.
21. Lamb RJ, Munn J, Duiker NJ, Coop A, Wu H, Koek W, France CP (2003). Interactions of γ-hydroxy butyrate with ethanol and NCS 382. Eur J Pharmacol 470:157-162.
22. Lingenhoehl K, Brom R, Heid J, Beck P, Froestl W, Kaupmann K, et al. (1999). Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. Neuropharmacology 38:1667-1673.
23. Longmire AW, Seger DL (1993). Topics in clinical pharmacology: flumazenil, a benzodiazepine antagonist. Am J Med Sci 306:49-52.
24. Maitre M, Andriamampandry C, Kemmel V, Schmidt C, Hode Y, Hechler V, Gobaille S (2000). Gamma-hydroxybutyric acid as a signaling molecule in brain. Alcohol 20:277-283.
25. Malgrange B, Rigo JM, Lefebvre PP, Coucke P, Goffin F, Xhauflaire G, et al. (1997). Diazepam-insensitive GABAA receptors on postnatal spiral ganglion neurones in culture. Neuroreport 8:591-596.
26. Nicholson KL, Balster RL (2001). GHB: a new and novel drug of abuse. Drug Alcohol Depend 63:1-22.
27. Overton DA (1983). Test for a neurochemically specific mechanism mediating drug discriminations and for stimulus masking. Psychopharmacology (Berlin) 81:340-344.
28. Siegel S, Castellan NJ Jr (1988). Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill.
29. Tallarida RJ (2000). Drug synergism and dose-effect data analysis. Boca Raton: Chapman & Hall/CRC.
30. Vayer P, Mandel P, Maitre M (1985). Conversion of gamma-hydroxybutyrate to gamma-aminobutyrate in vitro. J Neurochem 45:810-814.
31. Witkin JM, Barrett JE (1985). Behavioral effects and benzodiazepine antagonist activity of Ro 15-1788 (flumazepil) in pigeons. Life Sci 37:1587-1595.
32. Wong G, Skolnick P, Katz JL, Witkin JM (1993). Transduction of a discriminative stimulus through a diazepam-insensitive gamma-aminobutyric acid A receptor. J Pharmacol Exp Ther 266:570-576.
33. Woudenberg F, Slangen JL (1990). Characterisation of the discriminative stimulus properties of flumazenil. Eur J Pharmacol 178:29-36.